Skip to main content
. 2014 Sep 9;26(5):1195–1204. doi: 10.1681/ASN.2014010096

Table 1.

A cross-sectional comparison of baseline patient characteristics according to the rs6677604 genotype and mesangial C3 deposition

Characteristics Total rs6677604 Mesangial C3 Deposition
AA AG P Value 0 1+ 2+ 3+–4+ P Value
Patient numbers 365 39 326 28 47 114 176
Age (yr) 34.09±11.98 35.10±11.98 33.97±11.99 0.58 37.32±15.88 34.45±14.3 32.45±11.13 34.54±11.06 0.22
Sex (men/women) 194/171 (53.2%/46.8%) 22/17 (56.4%/43.6%) 172/154 (52.8%/47.2%) 0.67 16/12 (57.1%/42.9%) 24/23 (51.1%/48.9%) 64/50 (56.1%/43.9%) 90/86 (51.1%/48.9%) 0.81
eGFR (ml/min) 85.87±36.57 90.63±31.08 84.93±32.52 0.30 91.75±50.50 88.52±28.60 87.48±26.47 82.50±33.15 0.34
Proteinuria (g/d) 1.40 (0.80, 2.69) 1.51 (0.58, 2.59) 1.40 (0.78, 2.71) 0.55 1.38 (0.79, 4.91) 1.82 (0.75, 3.43) 1.42 (0.77, 2.45) 1.40 (0.81, 2.52) 0.70
SBP (mmHg) 124.2±14.3 121.3±14.0 124.6±14.3 0.17 124.5±11.4 126.5±21.0 122.8±12.8 124.5±13.5 0.50
DBP (mmHg) 79.2±11.0 79.6±12.1 79.1±10.9 0.78 78.8±9.4 79.2±14.4 77.6±10.5 80.2±10.5 0.26
Oxford classification
 M (M0/M1) 106/257 (29.2%/70.8%) 11/28 (28.2%/71.8%) 95/229 (29.3%/70.7%) 0.89 13/15 (46.4%/53.6%) 23/24 (48.9%/51.1%) 40/74 (35.1%/64.9%) 30/144 (17.2%/82.8%) <0.001a
 E (E0/E1) 140/223 (38.6%/61.4%) 15/24 (38.5%/61.5%) 125/199 (38.6%/61.4%) 0.99 10/18 (35.7%/64.3%) 19/28 (40.4%/59.6%) 38/76 (33.3%/66.7%) 73/101 (42.0%/58.0%) 0.45a
 S (S0/S1) 98/265 (27.0%/73.0%) 13/26 (33.3%/66.7%) 85/239 (26.2%/73.8%) 0.84 13/15 (46.4%/53.6%) 15/32 (31.9%/68.1%) 29/85 (25.4%/74.6%) 41/133 (23.6%/76.4%) 0.02a
 T (T0/T1/T2) 278/46/39 (76.6%/12.7%/10.7%) 34/4/1 (87.2%/10.3%/2.6%) 244/42/38 (75.3%/13.0%/11.7%) 0.17 26/2/0 (92.9%/7.1%/0.0%) 39/4/4 (83.0%/8.5%/8.5%) 85/20/9 (74.6%/17.5%/7.9%) 128/20/26 (73.6%/11.5%/14.9%) <0.01
a

P value for the linear-by-linear association chi-squared test.